About | HeinOnline Law Journal Library | HeinOnline Law Journal Library | HeinOnline
LOG IN
LOG IN

1 1 (January 10, 2020)

handle is hein.crs/govbcyz0001 and id is 1 raw text is: FF.ri E.$~ & Updated January 10, 2020 Congressionally Directed Medical Research Programs Funding for FY2020 Members of Congress are frequently lobbied to add funding to annual defense appropriation legislation for certain medical research programs on a wide variety of diseases and topics. In addressing annual appropriations bills, many Members frequently seek information on enacted levels for such funding under the Congressionally Directed Medical Research Programs (CDMRP). C'N1MP andtrauIc, r ,c; The CDMRP is a Department of Defense (DOD) program that receives congressional appropriations explicitly for biomedical research in specific, congressionally identified health matters. As such, it is not part of the President's budget request for the DOD. The U.S. Army Medical Research and Development Command (USAMRDC) administers the CDMRP and is responsible for awarding and managing competitive grants. Congress usually inserts CDMRP funding as Undistributed Medical Research in the Defense Health Program's Research, Development, Test, and Evaluation (RDT&E) account in the annual DOD appropriation. Congressional documents accompanying the annual defense appropriation act (i.e., conference reports or explanatory statements) identify the specific research areas for a given fiscal year. The Consolidated Appropriations Act, 2020 (P.L. 116-93), inserted $1.61 billion into the RDT&E account for CDMRP. This amount comprises 70% of the overall Defense Health Program's RDT&E appropriation, as reflected in Figure 1. Biomedical research conducted by the Defense Advanced Research Projects Agency or other military research agencies is not included in this account. Figure I. Total Defense Health Program RDT&E Appropriation, FY2020 . ..............iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii ...................== == = = = ===================== :::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: :! : iiiiiiiiiiiiiiiiiiiiiiiii................................ iiiiiiiii .........::::::::::::::::::::::::::::::::::::::: ....:::::::::::::::::::::::::::::::::::::::: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: :::::::::::::::::::::::::::::::::::::::::::..............:::::::::::::::::::::::::::::::::::::: ................:::::::::::::::::::::::::::::::::::: ..................:::::::::::::::::::::::::::::::::: ::.:', • == == =========================== ................................======================= .............. .......::::::::::::::::::::::::::: . ..................... ========= ............... ..............................~ii~~ii~~ii~~~ii~~ii~~iii~~ii~~ii~~~ii~~ii~~iii~~ii~~ii:i iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii ................................iiiiiiiiiiiiiiiiiiiiiiiiiiii:? ........ ................... ...... ...... ...... ......::::::::::::::::::::::::::::::::::::::::: ::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::::: ...... ......::::: ........ ....iii~ ~~~~~iiiii~ ~~~~iiiiii~ ~~~~iiiii~ ~~~~~iiiii~ ~~~~iiii .. . . . . . . .. iiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiiii . .=.=========================================================== .. .-.. . . ................ .:.................. . .. . . . ......... . ~ iiiiiiiiiiiiiiiiiii~ + ,~ fo Source: U.S. .ges Conernc Comtte ...xpla......tory... Statement ... acm ay g.. 1158. 116t.Con..Diisio.A.p.89A Table 1 lists the FY2020 CDMRP funding amounts for specific medical research areas. Table I. CDMRP Funding, FY2020 (in millions of dollars) Program Title Alzheimer's Disease Amyotrophic Lateral Sclerosis Autism Bone Marrow Failure Breast Cancer Chronic Pain Management Combat Readiness Duchenne Muscular Dystrophy Epilepsy Global HIV/AIDS Prevention Gulf War Illness Hearing Restoration HIV/AIDS Joint Warfighter Medical Kidney Cancer Lung Cancer Lupus Melanoma Multiple Sclerosis Orthotics and Prosthetics Outcomes Ovarian Cancer Pancreatic Cancer Peer- Reviewed Cancer Peer- Reviewed Medical Peer- Reviewed Orthopedic Prostate Cancer Psychological Health/Traumatic Brain Injury Rare Cancers Reconstructive Transplant Scleroderma Spinal Cord Injury Tick-Borne Disease Trauma Clinical Tuberous Sclerosis Vision Core Program Funding FY2020 15 20 15 3 150 15 10 10 12 8 22 10 15 40 40 14 10 20 16 15 35 6 110 360 30 110 165 7.5 12 5 40 7 10 6 20 232.1 TOTAL 1,615.6 Source: U.S. Congress, Conference Committee, Explanatory Statement accompanying H.R. 1158, 116th Cong., Division A, pp. 89B- 89C. p\w gnom ggmm mppm qq\ a , q 'S I 11LIANJILiN,

What Is HeinOnline?

HeinOnline is a subscription-based resource containing thousands of academic and legal journals from inception; complete coverage of government documents such as U.S. Statutes at Large, U.S. Code, Federal Register, Code of Federal Regulations, U.S. Reports, and much more. Documents are image-based, fully searchable PDFs with the authority of print combined with the accessibility of a user-friendly and powerful database. For more information, request a quote or trial for your organization below.



Short-term subscription options include 24 hours, 48 hours, or 1 week to HeinOnline.

Purchase Access

Already a HeinOnline Subscriber?

Log In

profiles profiles most